Retest early in the third Every 3 to 6 months if evaluation, and at trimester and at delivery if at increased risk least annually at high risk thereafter More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology TRICHOMONAS Consider for women receiving Recommended for care in high-prevalence settings sexually active (e.g., STD clinics and women at entry to correctional facilities) and for care and at least women at high risk for infection annually thereafter (e.g., women with multiple sex partners, exchanging sex for payment, illicit drug use, and a history of STD) HERPES Type-specific HSV serologic Evidence does not support Type-specific HSV Type-specific tests can Type-specific HSV testing should be considered routing HSV-2 serologic serologic testing be considered if serologic testing for women presenting for an screening among should be infection status is should be STD evaluation (especially for asymptomatic pregnant considered for unknown in MSM with considered for women with multiple sex women. However, men presenting previously persons presenting partners) serologic tests might for an STD undiagnosed genital for an STD be useful for identifying evaluation tract infection evaluation pregnant women at risk for (especially for (especially for those
Retest early in the third trimester and at delivery if at high risk Every 3 to 6 months if at increased risk evaluation, and at least annually thereafter More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology TRICHOMONAS Consider for women receiving care in high-prevalence settings (e.g., STD clinics and correctional facilities) and for women at high risk for infection (e.g., women with multiple sex partners, exchanging sex for payment, illicit drug use, and a history of STD) Recommended for sexually active women at entry to care and at least annually thereafter HERPES Type-specific HSV serologic testing should be considered for women presenting for an STD evaluation (especially for women with multiple sex partners) Evidence does not support routing HSV-2 serologic screening among asymptomatic pregnant women. However, serologic tests might be useful for identifying pregnant women at risk for Type-specific HSV serologic testing should be considered for men presenting for an STD evaluation (especially for Type-specific tests can be considered if infection status is unknown in MSM with previously undiagnosed genital tract infection Type-specific HSV serologic testing should be considered for persons presenting for an STD evaluation (especially for those